Posted on April 10, 20254/10/25
Unlock the Power of Indirect Treatment Comparisons (ITC) with Industry Experts
Posted on April 3, 20254/3/25
Beyond Clinical Trials: Real-World Evidence Illuminates the Value of First-Line CDK4/6i in Metastatic Breast Cancer
Posted on November 26, 202411/26/24
The Importance of Quality-of-Life Metrics in mCRPC
Posted on November 19, 202411/19/24
A Review of Indirect Treatment Comparisons (ITCs) in Regulatory Approval, Reimbursement and Pricing Recommendations for Oncology Drugs
Posted on November 4, 202411/4/24
Comparing First-Line Treatments for mCRPC: Insights From a Comprehensive NMA
Posted on October 25, 202410/25/24
New Insights into Brain Volume Loss in MS
Posted on September 20, 20249/20/24
RWEsearch 2024 | Innovating Clinical Trial Design with Real World Evidence
Posted on September 18, 20249/18/24
Enhancing Quality of Life in Advanced Breast Cancer: The Role of Palbociclib
Posted on September 17, 20249/17/24